Citius Pharmaceuticals upgraded by D. Boral Capital with a new price target
$CTXR
Biotechnology: Pharmaceutical Preparations
Health Care
D. Boral Capital upgraded Citius Pharmaceuticals from Hold to Buy and set a new price target of $9.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/30/2024 | $9.00 | Hold → Buy | D. Boral Capital |
| 1/18/2022 | $4.00 → $6.00 | Buy | HC Wainwright & Co. |
| 11/30/2021 | $4.00 | Buy | Maxim Group |